Skip to main content
. 2016 Sep 21;7(45):73984–73994. doi: 10.18632/oncotarget.12172

Table 3. Predictive value of biomarkers for progression-free survival (univariate analysis with continuous values).

HR 95%-CI p
Value at D1
VEGF-C (ng/ml) J0 0.93 (0.70-1.26) 0.66
sE-SELECTIN (ng/ml) J0 0.99 (0.94-1.04) 0.62
THROMBOSPONDIN (μg/ml) J0 0.99 (0.96-1.04) 0.96
VEGF (ng/ml) J0 1.96 (0.98-3.92) 0.06
PIGF (pg/ml) J0 0.98 (0.91-1.06) 0.68
SCF sR/c-kit (ng/ml) J0 0.99 (0.66-1.49) 0.98
Value at D7
VEGF-C (ng/ml) J7 0.91 (0.63-1.31) 0.61
sE-SELECTIN (ng/ml) J7 1.01 (0.96-1.06) 0.70
THROMBOSPONDIN (μg/ml) J7 0.98 (0.93-1.03) 0.39
VEGF (ng/ml) J7 2.15 (0.92-5.06) 0.08
PIGF (pg/ml) J7 1.01 (0.96-1.05) 0.84
SCF sR/c-kit (ng/ml) J7 1.04 (0.74-1.45) 0.83
Difference (D7-D1)
VEGF-C (ng/ml) J7 - J0 0.89 (0.45-1.77) 0.73
sE-SELECTIN (ng/ml) J7 - J0 1.07 (0.99-1.16) 0.08
THROMBOSPONDIN (μg/ml) J7 - J0 0.98 (0.93-1.03) 0.36
VEGF (ng/ml) J7 - J0 0.40 (0.04-3.91) 0.43
PIGF (pg/ml) J7 - J0 1.01 (0.97-1.06) 0.66
SCF sR/c-kit (ng/ml) J7 - J0 1.45 (0.53-3.95) 0.47